Stacy P. Smith, C-PA

Stacy Smith practices at Vero Beach Neurology And Research Institute in Vero Beach, Florida.

Stacy Smith's NPI, 1316930886, was assigned on August 30, 2005. Stacy Smith holds Florida license PA9101489.

Stacy Smith's primary practice is Vero Beach Neurology and Research Institute, at 1040 37th Pl Suite 201 Suite 201, Vero Beach, FL 32960-4818. The practice phone is (772) 492-7051.

Stacy Smith's primary practice is Vero Beach Neurology And Research Institute in Vero Beach, Florida. Stacy Smith is also affiliated with Cleveland Clinic Indian River Hospital. The medical group on file is Vero Beach Neurology and Research Institute. Dmand AI also links Stacy Smith to 2 more hospitals, 1 home health agency and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stacy Smith practices, 6 sites in all. Vendor and product names are available with a free account.

Medical is Stacy Smith's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Stacy Smith is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Stacy Smith is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, anxiety, arthritis, bladder disease, carpal tunnel syndrome, encephalopathy and epilepsy among the conditions Stacy Smith treats.

CMS data shows 2,079 Medicare services from Stacy Smith across 6 procedure codes in 2024, for 1,066 Medicare patients. Medicare paid $163,238 for them. Every service was in an office.

CMS counts 1,066 Medicare patients who saw Stacy Smith in 2024. The largest group is 75 to 84, with 492 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Stacy Smith's median patient age at 72, with 59% women.

In 2024, Stacy Smith wrote 1,583 Medicare Part D claims for 577 patients. 93% of them were for generic drugs. CMS names the drug for 1,296 of them, across 35 drugs with 11 or more claims each, at $387,317 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Stacy Smith for performance year 2024, reported as part of a group. Stacy Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stacy Smith as offering telehealth.

CMS Open Payments shows 208 general payments to Stacy Smith from 32 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 66% of the total. Abbvie Inc. paid the most, $3,028.